Sheharyar Raza: When More Testing Isn’t Always Better in Healthy Donor Screening
Sheharyar Raza, Transfusion Medicine Specialist and Data Scientist at University Health Network, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“In medicine we often say, ‘Don’t order a test if you don’t know what to do with the result’. This also applies to donor testing.
Out now in AABB journal Transfusion, co-authors (including Jeremy, Victoria et al) argue that although superficially appealing, extensive ‘wellness panels’ of tests pertormed in healthy people can have unexpected downsides that warrant cautious examination.
More information may not be beneficial when obtained in the presence of uncertain priors or follow-up, and may paradoxically undermine the goals it was sought to achieve.”
Title: Wellness testing in blood donation: A framework for responsible innovation
Authors: Jeremy W. Jacobs, Sheharyar Raza, Brian D. Adkins, Victoria Costa, David M. Chooljian, Garrett S. Booth
Read the Full Article on Transfusion
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 13:28Eduardo Medronha: DIPS as a Rescue Strategy in Budd–Chiari Syndrome
-
Aug 14, 2026, 13:18Immune Checkpoint Inhibitors Have Transformed Cancer Treatment – RPTH Journal
-
Aug 14, 2026, 13:04Mohammed M. Aboudeif: Cerebral Venous Thrombosis – Think Early, Treat Decisively
-
Aug 14, 2026, 12:49Ahmed Hawash: The Hawash Method for Managing Extreme ICU Complexity
-
Aug 14, 2026, 12:42Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma
-
Aug 14, 2026, 11:21Osama Alabdi: Never Ignore a Weak Reaction in the Blood Bank
-
Aug 14, 2026, 11:14Yohan Santin: How Lysosomal Dysfunction Drives Cardiac Aging